Cargando…
The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
While pharmacogenomic studies have facilitated the rapid expansion of personalized medicine, the benefits of these findings have not been evenly distributed. Genomic datasets pertaining to Indigenous populations are sorely lacking, leaving members of these communities at a higher risk of adverse dru...
Autores principales: | Nagaraj, Shivashankar H., Toombs, Maree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488351/ https://www.ncbi.nlm.nih.gov/pubmed/34616423 http://dx.doi.org/10.3389/fgene.2021.687116 |
Ejemplares similares
-
The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023) -
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
por: Ningtyas, Dian, et al.
Publicado: (2020) -
Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022) -
Population Pharmacogenomics for Precision Public Health in Colombia
por: Nagar, Shashwat Deepali, et al.
Publicado: (2019) -
Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2021)